Zydus Lifesciences Limited has informed the Exchange that Record date for the purpose of Buyback is 29-May-2026.
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty 100 and 1.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Zydus Lifesciences Limited's Board has approved a buyback of up to 95,65,217 fully paid-up equity shares (0.95% of total paid-up capital) at INR 1,150 per share. The maximum buyback size is INR 1,100 crore, representing 5.16% and 3.84% of the company's fully paid-up equity share capital and free reserves on standalone and consolidated basis respectively as of March 31, 2026. The buyback will be conducted through the tender offer route, open to all equity shareholders including promoters on a proportionate basis. The record date for determining eligible shareholders is May 29, 2026. Promoters currently hold approximately 75% of the company shares.
Shareholders get an opportunity to tender shares at INR 1,150 each, providing liquidity and potential gains if the buyback price is above market. However, the impact is limited given only 0.95% of shares are being bought back.